ACE and atrial fibrillation: It is noteworthy that majority of participants enrolled in these trials had advanced AF (persistent or permanent) and baseline use of background therapy with antiarrythmic drugs and multiple antihypertensive drugs including angiotensin-converting enzyme inhibitor (ACE I) was high with a modest difference in interarm BP during the trial.